Ganesh Benzoplast Limited has informed the Exchange about regulation 30 disclosure-intimation of resignation of CFO

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

GANESHBE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹78.90

prior close

₹79.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+0.4% vs market

Oil peers, median of 15sector · industry level-2.3%+1.9% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 1.9 pts more than its Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.0

15m

-0.3

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3-0.7+0.4-2.3+1.9

Next day

-2.2+0.2-2.4+0.4-2.5

+0.8+0.5+0.2+0.5+0.2

+1.3-0.9+2.2+0.6+0.6

+9.1-1.0+10.1+4.0+5.1

+11.4-0.9+12.3+3.2+8.2

+3.9-2.0+5.9+1.9+2.0

15d

-3.1-6.9+3.8+1.6-4.7

-1.5-10.5+9.0-4.6+3.0

+23.1+1.5+21.5+3.9+19.2

+17.7+3.8+13.9+10.2+7.5

UpDownMarket · Nifty Microcap 250Sector · Oil peers, median of 15Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ganesh Benzoplast Limited has informed the stock exchanges that its Chief Financial Officer, Mr. Ramesh Pilani, has tendered his resignation citing age (79 years) and health issues. The resignation was accepted by the Board on February 13, 2026, and will take effect from the close of business hours on May 12, 2026, giving roughly a three-month transition period. The Board has recorded its appreciation for his contributions. The company has stated it will make a separate announcement regarding the appointment of a new CFO in due course.

Likely market impact

This is a planned, health-related exit with a clear transition window until May 2026, reducing immediate disruption risk. Investors should watch for the new CFO appointment announcement, as leadership changes at the finance function can occasionally impact financial reporting continuity, though the orderly handover suggests minimal near-term concern.